Invited Speakers: The FDA Population PK/PD Modeling and Clinical Applications: Ken Kobayashi, Medical Officer, FDA
Pharmacodynamic Endpoint Bioequivalence: Simulation Study on Trial Design and Analysis, Chuanpu Hu, Sr. Staff Fellow, FDA
The Population Approach and Regulatory Submissions, Ene Ette, Vertex Pharmaceuticals
Program:
Succussful Use of Biomarkers and Surrogate Endpoints
Optimizing PK/PD Population Studies
Effective PK/PD Modeling and Design
Accelerating PK/PD Drug Development
Genotyping to Improve PK/PD Analyses During Drug Evaluation and Development
Registration :
contact: customer.service@parexel.com or 800-856-2556, fax: 610-565-4842
Deadline for Abstracts: closed
Email for Requests and Registration: customer.service@parexel.com